Table 2.
Comparison of 90-day outcome between patients under GA and CS
| Outcome variable | GA | CS | Univariate analysis | Multivariable analysis | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | ||||||||
| cOR (95% CI) | P value | aOR (95% CI) | P value | aOR (95% CI) | P value | aOR (95% CI) | P value | |||
| Functional independence (mRS 0–2) at 90 days | 43/139 (30.9) | 24/39 (61.5) | 0.28(0.13–0.59) | < 0.01 | 0.31(0.13–0.75) | 0.01 | 0.29 (0.09–0.97) | 0.045 | 0.31(0.10–0.97) | 0.045 * |
| Favorable outcome (mRS 0–3) at 90 days | 60/139 (43.2) | 30/39 (76.9) | 0.23(0.10–0.52) | < 0.01 | 0.26(0.10–0.64) | < 0.01 | 0.25 (0.07–0.83) | 0.02 | 0.24(0.07–0.75) | 0.02 † |
| Death at 90 days | 29/139 (20.9) | 3/39 (7.7) | 3.16(0.91–11.01) | 0.07 | 2.57(0.70–9.52) | 0.16 | 3.36 (0.48–23.68) | 0.22 | 2.99(0.46–19.74) | 0.25 ‡ |
Model 1 adjusted for age, sex, from vascular occlusion to puncture, NIHSS score
Model 2 adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, Mode of stroke onset, Blood glucose, Use of Solitaire retriever, Infusion of Tirofiban, Angioplasty
GA indicates general anesthesia, CS conscious sedation, cOR crude odds ratio, aOR adjusted odds ratio, CI confidence interval, mRS modified Rankin Scale
*Adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, angioplasty, anesthesia time
†Adjusted for age, sex, from vascular occlusion to puncture,NIHSS score, use solitaire retriever, blood glucose, anesthesia time
‡Adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, blood glucose, use of solitaire, angioplasty, anesthesia time